Probiotics and Intestinal Gas: Do They Actually Help?
Probiotics are marketed as a cure-all for gut problems — and there is indeed scientific evidence that certain bacterial strains can reduce flatulence. The catch: in the first weeks of taking them, some probiotics initially produce more gas. When do probiotics help, when do they hinder, and which strains are actually evidence-based for bloating?
What Are Probiotics and How Do They Work?
Probiotics are living microorganisms that — when taken in sufficient quantities — have a health benefit for the host. The most commonly used strains belong to the genera Lactobacillus and Bifidobacterium; the yeast Saccharomyces boulardii is also widely used. In the gut, probiotics compete with existing microorganisms for resources and niches, produce substances (bacteriocins, short-chain fatty acids) that inhibit the growth of gas-producing bacteria, and modulate the immune response of the gut wall. They don't 'replace' the existing gut flora — they shift the balance slightly.
The Initial Worsening: Why More Gas at First?
A frequently reported phenomenon when starting probiotics is an initial increase in bloating in the first 1–2 weeks. The reason: the ingested bacterial strains need time to find a niche in the gut. During this establishment phase they can enter into fermentation processes with existing microorganisms that initially produce more gas. Additionally, some Lactobacillus strains themselves produce CO₂ as a metabolic by-product. This initial phase is normal and not a sign of failure — in many users the symptom level normalises after 2–4 weeks and then falls below the baseline.
Which Strains Help With Bloating?
Scientific evidence is strain-specific — general statements about 'probiotics' are not very meaningful. The best evidenced are: Lactobacillus plantarum 299v (several randomised studies in IBS show reduction in bloating and abdominal pain), Bifidobacterium infantis 35624 (clinical studies in IBS patients, significant improvement in bloating scores), Lactobacillus rhamnosus GG (well evidenced for post-antibiotic dysbiosis), Saccharomyces boulardii (particularly for traveller's diarrhoea and antibiotic-associated diarrhoea). Important: not everyone responds the same way. Individual gut flora largely determines which strain is useful — an area where personalised microbiome medicine is actively being researched.
Evidence Base and Critical Assessment
The scientific evidence for probiotics is complex. While many studies show positive effects, quality and methodology are very heterogeneous. The European Food Safety Authority (EFSA) has so far approved no single probiotic-based health claim as sufficiently proven — which does not prevent manufacturers from marketing their products intensively. For patients with irritable bowel syndrome (IBS), a meta-analysis of 15 randomised studies (2020) shows a statistically significant but clinically moderate improvement in bloating symptoms. For healthy people without specific gut problems, the effect of probiotics on bloating is less clearly evidenced. For persistent severe complaints, always consult a doctor.
Did you know?
- Probiotics can initially produce more gas in the first weeks — this is normal and not a sign of failure.
- Not all probiotics are alike: the effect is strain-specific. Lactobacillus plantarum 299v is best evidenced for bloating.
- The EFSA has so far officially approved no single probiotic-based health claim.
- Saccharomyces boulardii is a yeast, not a bacterium — and yet officially a probiotic.
Fun Fact
In a study at the University of Copenhagen, the gut flora composition of identical twins who took the same probiotic for 3 months was compared. The result: the gut flora response was as different between the twins as between strangers — evidence that even genetically identical people have completely different gut ecosystems.
Sources
- Ford, A.C. et al. (2018). Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome. American Journal of Gastroenterology, 113(9), 1366–1376.
- O'Mahony, L. et al. (2005). Lactobacillus and bifidobacterium in irritable bowel syndrome. Gastroenterology, 128(3), 541–551.
- Lozupone, C.A. et al. (2012). Diversity, stability and resilience of the human gut microbiota. Nature, 489, 220–230.
- EFSA Panel on Dietetic Products, Nutrition and Allergies (2011). Scientific Opinion on the substantiation of health claims related to live yoghurt cultures.